15 Unheard Ways To Achieve Greater Xarelto Lawsuit

From AwkwardTV
Jump to: navigation, search

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, such as the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are operating challenging to get those hurt by the drug the compensation they're entitled to.

Although bleeding is a common complication linked with anticoagulants, it has been alleged that Xarelto is a lot more harmful than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This signifies that, in the occasion of an emergency, sufferers might be at risk for irreversible bleeding problems, such as life-threatening internal and gastrointestinal hemorrhaging.

In case you or a loved one suffered a critical bleeding event right after taking Xarelto, you may have legal recourse. For a lot more info, speak to us right now to have your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenditures. Moreover, they're in search of punitive damages, which are usually awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections learn here from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.